ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The foundation started by tech billionaire Sean Parker is putting up $250 million to create the Parker Institute for Cancer Immunotherapy, which will support 300 researchers across six academic cancer centers. The institute plans to develop cell-based therapies, expand the number of patients who benefit from checkpoint therapies, and find tumor antigen targets that could lead to cancer vaccines. Any intellectual property it generates will be licensed or spun off into a company, with proceeds being divided between the institute and the six academic sites.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter